Mainz Biomed N.V.
QUCY
$0.43
-$0.03-6.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.95% | 18.28% | -- | -- | -- |
| Total Depreciation and Amortization | -11.60% | -17.92% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.34% | 73.40% | -- | -- | -- |
| Change in Net Operating Assets | -2,090.62% | -334.92% | -- | -- | -- |
| Cash from Operations | 36.64% | 23.30% | -- | -- | -- |
| Capital Expenditure | 98.85% | 102.44% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -23.93% | 76.07% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 0.00% | -- | -- | -- |
| Other Investing Activities | -600.00% | -107.69% | -- | -- | -- |
| Cash from Investing | -419.82% | -10.48% | -- | -- | -- |
| Total Debt Issued | -- | -81.59% | -- | -- | -- |
| Total Debt Repaid | -15.72% | 37.12% | -- | -- | -- |
| Issuance of Common Stock | -40.08% | 7.53% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -59.72% | -9.88% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 1.63% | 91.62% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -540.16% | 61.38% | -- | -- | -- |